TITLE

Antibody Maturation and Viral Diversification in HIV-Infected Women

AUTHOR(S)
James, Maria M.; Laeyendecker, Oliver; Sun, Jin; Hoover, Donald R.; Mullis, Caroline E.; Cousins, Matthew M.; Coates, Thomas; Moore, Richard D.; Kelen, Gabor D.; Fowler, Mary Glenn; Kumwenda, Johnstone J.; Mofenson, Lynne M.; Kumwenda, Newton I.; Taha, Taha E.; Eshleman, Susan H.
PUB. DATE
February 2013
SOURCE
PLoS ONE;Feb2013, Vol. 8 Issue 2, p1
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Introduction: The Post-exposure Prophylaxis in Infants (PEPI)-Malawi trial evaluated infant antiretroviral regimens for prevention of post-natal HIV transmission. A multi-assay algorithm (MAA) that includes the BED capture immunoassay, an avidity assay, CD4 cell count, and viral load was used to identify women who were vs. were not recently infected at the time of enrollment (MAA recent, N = 73; MAA non-recent, N = 2,488); a subset of the women in the MAA non-recent group known to have been HIV infected for at least 2 years before enrollment (known non-recent, N = 54). Antibody maturation and viral diversification were examined in these women. Methods: Samples collected at enrollment (N = 2,561) and 12–24 months later (N = 1,306) were available for serologic analysis using the BED and avidity assays. A subset of those samples was used for analysis of viral diversity, which was performed using a high resolution melting (HRM) diversity assay. Viral diversity analysis was performed using all available samples from women in the MAA recent group (61 enrollment samples, 38 follow-up samples) and the known non-recent group (43 enrollment samples, 22 follow-up samples). Diversity data from PEPI-Malawi were also compared to similar data from 169 adults in the United States (US) with known recent infection (N = 102) and known non-recent infection (N = 67). Results: In PEPI-Malawi, results from the BED and avidity assays increased over time in the MAA recent group, but did not change significantly in the MAA non-recent group. At enrollment, HIV diversity was lower in the MAA recent group than in the known non-recent group. HRM diversity assay results from women in PEPI-Malawi were similar to those from adults in the US with known duration of HIV infection. Conclusions: Antibody maturation and HIV diversification patterns in African women provide additional support for use of the MAA to identify populations with recent HIV infection.
ACCESSION #
87625395

 

Related Articles

  • Family sues over death of Memphis woman killed by AIDS treatment.  // Gay & Lesbian Times;1/6/2005, Issue 889, p31 

    Reports that the family of pregnant HIV-positive Joyce Ann Hafford who died while taking an experimental AIDS drug regimen has filed a lawsuit in Memphis, Tennessee. Physicians, pharmaceutical companies, and hospitals involved in the clinical trial as defendants; Drug regimen included the...

  • Antiretroviral Drug Use in a Cohort of HIV-Uninfected Women in the United States: HIV Prevention Trials Network 064. Chen, Iris; Clarke, William; Ou, San-San; Marzinke, Mark A.; Breaud, Autumn; Emel, Lynda M.; Wang, Jing; Hughes, James P.; Richardson, Paul; Haley, Danielle F.; Lucas, Jonathan; Rompalo, Anne; Justman, Jessica E.; Hodder, Sally L.; Eshleman, Susan H. // PLoS ONE;10/7/2015, Vol. 10 Issue 10, p1 

    Antiretroviral (ARV) drug use was analyzed in HIV-uninfected women in an observational cohort study conducted in 10 urban and periurban communities in the United States with high rates of poverty and HIV infection. Plasma samples collected in 2009–2010 were tested for the presence of 16...

  • Is Option B+ the best choice? Coutsoudis, A.; Goga, A.; Desmond, C.; Barron, P.; Black, V.; Coovadia, H. // Southern African Journal of HIV Medicine;Mar2013, Vol. 14 Issue 1, p8 

    The success of prevention of mother-to-child transmission (PMTCT) programmes (Options A and B) in middle-income countries, together with clinical trial data on antiretroviral (ARV) treatment as prophylaxis, has emboldened UN agencies to aggressively promote lifelong ARVs for PMTCT (Option B+)....

  • Debate about breast-feeding recommendations for infants with HIV continues. Blazek, Nicole // Infectious Diseases in Children;Sep2008, Vol. 21 Issue 9, p60 

    The article discusses two clinical trials published in "The New England Journal of Medicine" which focused on developing infant-feeding policies for women with HIV in low-resource settings. The first study examined breast-feeding cessation in babies while the second study looked at the interplay...

  • Sex-Based Outcomes of Darunavir-Ritonavir Therapy. Currier, Judith; Bridge, Dawn Averitt; Hagins, Debbie; Zorrilla, Carmen D.; Feinberg, Judith; Ryan, Robert; Falcon, Ron; Tennenberg, Alan; Mrus, Joseph; Squires, Kathleen // Annals of Internal Medicine;9/21/2010, Vol. 153 Issue 6, p349 

    Background: Women account for an increasing proportion of patients with HIV-1 but remain underrepresented in antiretroviral clinical trials. Objective: To evaluate sex-based differences in efficacy and adverse events in treatment-experienced, HIV-positive women and men receiving...

  • Antiretroviral Drug Use during Pregnancy and Risk of Premature Delivery: Is There a Connection? Kourtis, Athena P. // Journal of Infectious Diseases;4/1/2010, Vol. 201 Issue 7, p978 

    In this article the author discusses the study by Kunjal Patel and colleagues which determines the relation of using antiretroviral therapy during pregnancy and the risk of premature delivery. He states that the study is a significant step in elucidating the subject matter at issue, but stresses...

  • Brazilian and international guidance on breasfeeding for infants of HIV - infected mothers. Herrero, Dafne; Gonçalves de Oliveira, Adriana; Motta-Gallo, Sophia; Gallo, Paulo Rogerio; Souza, Sandra Regina; Goulart, Flávia Cristina; de Siqueira, Arnaldo Augusto Franco; Mello Monteiro, Carlos Bandeira; Fujimori, Mahmi; Vinhas Bertolini, Daniela; de Abreu, Luiz Carlos // HealthMed;2014, Vol. 8 Issue 10, p1123 

    Introduction: the moment of breastfeeding becomes one of the first contacts between mother and infant. Breastfeeding in infants of mothers living with AIDS is oriented divergently from the United Nations Children's Fund (UNICEF) and the Ministry of Health of Brazil, regarding the current...

  • Primary HIV-1 infection during pregnancy: high rate of HIV-1 MTCT in a cohort of patients in southern Brazil. Nielsen-Saines, Karin; Melo, Marineide; Varella, Ivana; Fonseca, Rosana; Lira, Rita; Turella, Maria Lourdes; Canti, Ivete; Campello, Claudio; Moreira, Ana Maria; Santos, Breno Riegel // Retrovirology;2008 Supplement 1, Vol. 5, Special section p1 

    Background Mother to Child HIV-1 Transmission (MTCT) is infrequent among women who receive highly active antiretroviral therapy (HAART) throughout pregnancy. Women who undergo primary HIV-1 infection during pregnancy, however are at high risk of perinatal transmission. Materials and methods MTCT...

  • An unusual case of hyperlactataemia in a neonate. Nirupam, Nilay; Nangia, Sushma; Kumar, Ajay; Saili, Arvind // International Journal of STD & AIDS;Dec2013, Vol. 24 Issue 12, p986 

    We report a HIV uninfected neonate born to HIV positive mother, who had tachypnoea at birth. On investigations, he was found to have hyperlactataemia. All the secondary causes for elevated lactate were ruled out. Hyperlactataemia was attributed to the perinatal exposure, to maternal...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics